|Primary analysis complete
|Study Start Date:
|Study Made Public:
A randomized, double blind Phase 1b trial to examine the influence of antigenic competition on the immunogenicity of HIV-1 gag-pol: A comparison of rAd5 gag-pol/env A/B/C to rAd5 gag-pol
HVTN 084 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of VRCHIVADV014-00-VP (rAd5) and VRCHIVADV052-00-VP (rAd5).
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.